These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 36778079)

  • 1. Payout suspensions during the Covid-19 pandemic.
    Pettenuzzo D; Sabbatucci R; Timmermann A
    Econ Lett; 2023 Mar; 224():111024. PubMed ID: 36778079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corporate payout, cash holdings, and the COVID-19 crisis: Evidence from the G-7 countries.
    Ntantamis C; Zhou J
    Financ Res Lett; 2022 Dec; 50():103275. PubMed ID: 36034341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dividend suspensions and cash flows during the Covid-19 pandemic: A dynamic econometric model.
    Pettenuzzo D; Sabbatucci R; Timmermann A
    J Econom; 2023 Aug; 235(2):1522-1541. PubMed ID: 36714078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the COVID-19 pandemic on dividends.
    Krieger K; Mauck N; Pruitt SW
    Financ Res Lett; 2021 Oct; 42():101910. PubMed ID: 34566530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dividend policy and crisis: Exploring the interplay between performance and financial constraints in the French context.
    Theiri S; Ben Hamad S; Ben Amor M
    Heliyon; 2023 Oct; 9(10):e20586. PubMed ID: 37842631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is cash the panacea of the COVID-19 pandemic: Evidence from corporate performance.
    Zheng M
    Financ Res Lett; 2022 Mar; 45():102151. PubMed ID: 35221815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Share repurchase and the cost of capital: Discussion on the nature of share repurchase of Chinese listed companies.
    Wang P; Chen R
    PLoS One; 2023; 18(9):e0292171. PubMed ID: 37768999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the market biased in M&A, dividend payment, and share repurchase events?
    Quang LT
    Heliyon; 2024 Apr; 10(8):e29400. PubMed ID: 38644856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corporate dividend policy in the time of COVID-19: Evidence from the G-12 countries.
    Ali H
    Financ Res Lett; 2022 May; 46():102493. PubMed ID: 34658678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Financing constraints and firm-level responses to the COVID-19 pandemic: International evidence.
    Khan SU
    Res Int Bus Finance; 2022 Jan; 59():101545. PubMed ID: 34580554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volatility of Tax Payments and Dividend Payouts.
    Amberger HJ
    Contemp Account Res; 2023; 40(1):451-487. PubMed ID: 38528965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Firms' COVID-19 Pandemic Exposure and Corporate Cash Policy: Evidence from China.
    He Z; Suardi S; Wang K; Zhao Y
    Econ Model; 2022 Nov; 116():105999. PubMed ID: 36032988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 impact on firm investment-Evidence from Chinese publicly listed firms.
    Jiang J; Hou J; Wang C; Liu H
    J Asian Econ; 2021 Aug; 75():101320. PubMed ID: 36567767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dividend announcement effect analysis before and during the COVID-19 pandemic in the Indonesia Stock Exchange.
    Robiyanto R; Yunitaria F
    SN Bus Econ; 2022; 2(2):20. PubMed ID: 35075449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of capital structure management in maintaining the financial stability of hotel firms during the pandemic-A global investigation.
    Thi Mai Nguyen L; Le D; Vu KT; Tran TK
    Int J Hosp Manag; 2023 Feb; 109():103366. PubMed ID: 36447774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Firms' responses to the COVID-19 pandemic.
    Klöckner M; Schmidt CG; Wagner SM; Swink M
    J Bus Res; 2023 Mar; 158():113664. PubMed ID: 36685011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Behavioral Foundations and Business Strategy on Corporate Dividend Policy.
    Liao WJ; Lin YE; Li XZ; Chih HH
    Front Psychol; 2022; 13():849238. PubMed ID: 35401304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of COVID-19 on the valuations of non-financial European firms.
    Abbas Rizvi SK; Yarovaya L; Mirza N; Naqvi B
    Heliyon; 2022 Jun; 8(6):e09486. PubMed ID: 35634174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The COVID-19 outbreak and corporate cash-holding levels: Evidence from China.
    Zhou D; Zhou H; Bai M; Qin Y
    Front Psychol; 2022; 13():942210. PubMed ID: 36324775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suspension of insurers' dividends as a response to the COVID-19 crisis: evidence from the European insurance equity market.
    Jakubik P; Teleu S
    Geneva Pap Risk Insur Issues Pract; 2022; 47(4):785-816. PubMed ID: 34629828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.